Author

S. Upadhyay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Approach:experimental assay· 2 Assay:proteomics· 2 Organism:C. elegans· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Godbole· 1 shared A. Nazeer· 1 shared A. Pansari· 1 shared B. S. Sahu· 1 shared C. Mukherjee· 1 shared H. Kalonia· 1 shared J. Cai· 1 shared K. Morishita· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Godbole

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Novel Nuclear Roles for Testis-Specific ACTL7A and ACTL7B Supported by In Vivo Characterizations and AI Facilitated In Silico Mechanistic Modeling with Implications for Epigenetic Regulation in Spermiogenesis.

P. Ferrer, S. Upadhyay, J. Cai, T. M. Clement

This study identifies nuclear roles for testis-specific ACTL7A and ACTL7B in chromatin regulation during spermiogenesis, supported by in vivo data and AI-enhanced in silico modeling.

bioRxiv · Feb 29, 2024 · PreprintCell Biology

Sida cordifolia, a medicinal plant is efficacious in models of Huntingtons disease, by reducing ER stress

P. K. Simha, C. Mukherjee, V. K. G. K. Gupta, N. M. Sapariya, P. Nagar, A. Nazeer, A. Godbole, B. S. Sahu, S. Upadhyay

This study shows that Sida cordifolia extract reduces mutant huntingtin protein aggregation in Huntington's disease models, improving motility and lifespan in worms and reducing ER stress in cells.

bioRxiv · Nov 1, 2023 · PreprintPharmacology & Toxicology

Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma.

S. A. Visaga, H. Kalonia, V. Verma, S. Sinha, S. K. Singh, S. Upadhyay, S. Sahdev, A. Pansari, R. Kumar, M. Bandgar, N. Karanjule, R. K. Shirumalla, K. Morishita, R. Tandon

The paper develops selective FPR2 agonists and shows they reduce non-resolving inflammation in asthma models.

bioRxiv · Sep 16, 2021 · PreprintPharmacology & Toxicology